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Abstract
Objective—Neonatal male circumcision (NMC) is not routinely practiced in Zambia, but it 
promising long-term HIV prevention strategy. We studied the feasibility and safety of three 
different NMC methods
Patients and Methods—We enrolled healthy newborns in a controlled trial of the Mogen, 
Gomco, and Plastibell devices. Doctors, nurses, and clinical officers were trained to perform 
Mogen, Gomco, and Plastibell techniques. Each provider performed at least 10 circumcisions 
using each device. Neonates were reviewed at one week and six weeks post circumcision for 
adverse events.
Results—Between October 2009 and March 2011, 17 providers (5 physicians, 9 nurse-
midwives, and 3 clinical officers) without prior NMC experience were trained, and 640 
circumcisions performed. The median infant birth weight was 3.2kg (IQR 2.9–3.5 kg) and median 
age at the time of procedure was 11 days (IQR:7–18 days); 149 babies (23.3%) were HIV-
exposed. The overall adverse event rate was 4.9% (n=31/630), and the moderate-severe AE rate 
was 4.1% (n=26/630). Write in what this was. Rates did not significantly differ by method. Most 
providers (65%) preferred the Mogen clamp over the Gomco and Plastibell.
Conclusions—Doctors, nurses, and clinical officers can be trained to safely provide NMC in a 
programmatic setting. The three studied techniques had comparable safety profiles. Mogen clamp 
was the preferred device for most providers.
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As early as 2001, ecological studies first suggested that countries with widespread coverage 
of male circumcision, such as those in West Africa, had lower burdens of HIV infection. (1–
4) Subsequently, three large randomized trials in sub-Saharan Africa have conclusively 
shown that male circumcision (MC) reduces HIV acquisition among heterosexual men by up 
to 60%.(5–7) Based on these findings, the World Health Organization (WHO) and UNAIDS 
recommended MC scale up as one component of a comprehensive HIV prevention strategy 
for settings of low MC prevalence and high HIV prevalence.(8) While adolescents and 
young adults are the primary targets for most prevention-oriented MC programs, to 
maximize long-term HIV prevention benefits, circumcision programs have also begun 
targeting male infants.
Neonatal male circumcision (NMC) (or circumcision within the first couple of months of 
life) is generally regarded as a cheaper, simpler and safer procedure compared to 
circumcision of older boys and men (9, 10). In industrialized-country settings, the procedure 
is commonly performed using one of three specialized devices (Mogen Clamp, Plastibell, or 
Gomco) designed to achieve hemostasis without sutures. Complication rates among the 
three devices are similar (11), and choice among the devices is usually determined by 
provider preference (12–14). The WHO recommends all three of these methods in addition 
to the dorsal slit method for neonatal circumcision (15).
Although neonatal male circumcision is rarely practiced in Zambia, the Ministry of Health 
of Zambia has ambitious plans to reach 80% of all male infants with NMC by 2020 (16). We 
conducted a neonatal male circumcision study to determine the acceptability, feasibility, and 
safety of neonatal circumcision. The goal was to advise the Zambian Ministry of Health on 
the best method for national scale up. In this manuscript, we report on device preference 
among different types of providers as well as safety.
Patients and Methods
Study Setting
We conducted a prospective trial of neonatal male circumcision in 3 Lusaka sites: the 
University Teaching Hospital (UTH), and two public-sector primary health care clinics. 
Neonatal vitamin K is not routinely used in our setting and was not administered to 
participants in our trial.
Recruitment and Training of NMC Providers
Prior to participant enrollment, we developed an NMC training package consisting of 
didactic lectures, practice on models of neonatal genitalia, and clinical practice. Nine 
physicians from the UTH were trained to serve as NMC supervisors for provider trainees 
enrolling in the study. During the study, these supervisors evaluated the competence of the 
trainees at set intervals, examined infants at review visits, and assessed adverse events.
Provider trainees, including physicians, clinical officers, nurse midwives, and registered 
nurses. After completing informed consent to participate in the study of NMC provider 
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training, providers were trained in groups consisting of 2-to-4 trainees depending on the 
availability of trainees. The individual methods were taught sequentially and in blocks. If a 
supervisor determined that a trainee was not competent in a given method after 10 
procedures, then the provider would perform that particular method until competency and 
before moving on to another method. To ensure variation in the sequence of the three 
methods among trainees (assuming sequence could influence their competence and 
preferences among methods), the order of NMC methods for each provider was pre-
determined by an independent statistician. (Table 1) Providers were blinded to the sequence. 
Blinding the postoperative evaluations was not possible since the Plastibell technique 
involves a small plastic bell remaining on the penis for up to a week and the other two 
techniques did not
NMC Provider Trainee Evaluations
The supervisors evaluated trainees using standard competency checklists (tailored to the 
procedure type being evaluated) after every five procedures. The trainees completed pre-and 
post-training questionnaires, to assess their knowledge, attitudes and previous experience 
with male circumcision, as well as their NMC method preferences (post-training only).
Informed Consent and Eligibility Screening
Parents of newborn boys were recruited for the study by peer educators in the post-natal 
wards of the three NMC sites and other public clinics. One or both parents (if available) or 
legal guardians of eligible infants completed an informed consent process prior to their 
infant’s circumcision. All healthy male infants of gestational age >37 weeks at birth, aged 
0–28 days, and between 2,500 grams and 5,000 grams were considered eligible to be in the 
study. Infants with urethral or penile shaft abnormality, local infection, any current illness, 
or family history of bleeding disorder were excluded. Testing of mothers and infants for 
HIV was not offered in the study. However all pregnant mothers are routinely tested for HIV 
under the Ministry of Health policy guidelines.
NMC Method Selection
Participating infants received a dorsal nerve block using 0.8ml of 1% lignocaine for local 
anesthesia, and were given up to one ml of an oral glucose solution, administered using a 
pacifier for analgesia during the procedure. Infants were then circumcised using one of the 
three NMC methods being trained (Mogen, Gomco, or Plastibell). The method performed on 
a given infant was determined based on which method was being practiced by the attending 
provider trainee at the time of the procedure, as previously described. For each circumcision 
performed, information such as provider, location, type of procedure used, procedure start 
and end time, and individual infant characteristics as well as parental characteristics were 
recorded on standard clinic forms.
Infant Follow Up
Study staff performed a detailed physical exam on all infants at one week and six weeks 
following the procedure using standardized follow-up forms to guide their examinations. At 
infants’ six weeks visits, parents completed a satisfaction survey during which they were 
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asked to rate their level of satisfaction with the procedure outcome using a scale between 0 
and 100, where 0 = not at all satisfied, and 100 = completely satisfied. Study participants 
who missed their scheduled visits were followed up at home.
Evaluation of Adverse Events
Any observed complication was referred to study staff and recorded on an adverse events 
form. We categorized adverse events as mild, moderate, or severe based on criteria 
previously defined by the WHO(17). Mild bleeding episodes were defined as requiring 
pressure to control, moderate events required placement of a suture, and severe events were 
those requiring transfusion. We defined mild infections as requiring local cleaning, a 
moderate one as needing application of topical antibiotic ointment, and severe ones as 
requiring systemic antibiotics. A surgical revision was always classified as a severe cosmetic 
adverse event.
Data Analysis
Descriptive statistics were used to summarize provider characteristics, parental and infant 
characteristics. Differences in provider, parent and infant characteristics between the three 
neonatal male circumcision methods were compared using the nonparametic Kruskal-Wallis 
test for continuous variables and the Pearson Chi-square test for categorical variables. 
Providers ranked the three methods according to preference and ease of use, and the method 
with the highest rank was tallied. Mean parent satisfaction scores and procedure times were 
compared across the three circumcision methods, first using a one–way ANOVA model. 
Pairwise differences were evaluated using the Tukey’s HSD test to control for multiple 
comparisons.
The classification of the adverse event status for each participant was conducted in two 
ways. First, participants with missing follow up data were treated as missing at random and 
removed from the denominator of all calculations. A separate sensitivity analysis classifying 
these missing patients as having an adverse event provided a conservative estimate of the 
upper bound for the percentage of adverse events. Adverse events were also tabulated by 
infant characteristics (such as HIV exposure status, age at procedure, birth and procedure 
weight) and provider characteristics, including provider type. Although the study was not 
powered to detect any specific differences in adverse events between the three circumcision 
methods, a safety analysis was performed for the descriptive comparison of the methods. 
Data was summarized in terms of percentage of infants experiencing an adverse event at 
each follow-up visit. Separate comparisons between categorizations of adverse events and 
between each circumcision method were made using Fisher’s exact test. All statistical 
analyses were performed using SAS version 9.1.3 (SAS Institute Inc., Cary, North 
Carolina).
Sample Size
Our sample size was predetermined and based on convenience. Our goal was to train 15–20 
providers, who would perform at least 10 circumcisions in each of three methods, for a total 
of approximately 600 circumcisions (200 per method). Enrollment of infants ended once all 
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healthcare providers had completed at least 30 procedures and reached competency. Some 
providers completed more than 30 procedures; all procedures were included in the analysis.
The study protocol and informed consent documents underwent continuing ethical review 
from the relevant Institutional Review Boards at the University of Zambia, the University of 




Between October 27, 2009 and March 24, 2011, we enrolled 17 providers into our study, 
each of whom performed at least 30 circumcisions (10 of each method). 661 infants were 
enrolled and 21 (3.2%) were excluded due to ineligibility after enrolling. Infants were 
excluded from the study if they were older than 28 days, had an infection or illness at the 
time of the procedure, or if they had pustules or blisters on their body. These infants did not 
undergo circumcision. (Figure 1) The total number of circumcisions performed was 640. Six 
of the 17 providers (35%) were male, 5 were doctors, 3 were clinical officers, and 9 were 
nurses or midwives. Of the doctors, 1 was a surgeon. None of the providers had previous 
experience performing neonatal circumcision, but 5 had experience with adult circumcision. 
6 providers were trained in Plastibell first, 6 providers performed Mogen first, and 5 
providers were trained in Gomco methods first.
Infant and parent characteristics
635/640 (99%) had a one week follow up visit and 630/640 (98%) were seen at six weeks 
post-procedure. The median age of the infants at time of circumcision was 11 days (IQR 7–
18 days). Approximately 11% were less than 48 hours at the time of the procedure. The 
median birthweight was 3.2 kg (IQR: 2.9–3.5 kg) and the median weight at the time of the 
procedure was 3.6 kg (IQR: 3.2–4.0 kg). 23.3% (149/624) were HIV exposed, and 17.2% 
were delivered by cesarean section. None of these infant characteristics differed by 
circumcision method. (Table 1) Parental characteristics are described in Table 3. The 
median age of infant’s mothers was 28 years (IQR:24–32 years) and 34 years (IQR: 30–38 
years) for the fathers. The majority of mothers reported being married (92.6%). 70% had a 
household income greater than $200 US Dollars/month. More than half of all fathers 
(51.0%) were circumcised. Overall 10.7% of mothers were Muslim and 11.3% of fathers 
were Muslim. Infants circumcised by the Mogen group were more likely to have a Muslim 
mother (p=0.001), and have a Muslim father (p<0.001).
Parental Preferences
For the 613 mothers and 64 fathers who completed a satisfaction survey, mean satisfaction 
score for mothers and fathers was 96.4 (SD 7.5) and 95.9 (SD 8.2), respectively, based on a 
scale from 0 (very dissatisfied) to 100 (very satisfied). Parental satisfaction scores did not 
differ significantly by method and no pair-wise differences between any two methods was 
found.
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Provider Preferences and procedures
11/17 providers (65%) preferred the Mogen clamp to the Gomco or the Plastibell. (Table 3) 
The majority of providers (15/17, 88%) also found that the Mogen clamp was the easiest to 
perform. (Table 3) The mean duration of the procedures differed significantly by method 
and was 11.5 minutes (SD: +/− 6.7) for the Mogen clamp, 13.9 minutes for the Gomco (SD=
+/−6.3), and 11.9 minutes for the Plastibell (SD: +/−4.0)(p<0.001). Tukey-adjusted pairwise 
comparisons indicated that the duration of the Gomco procedure was 2.4 minutes longer 
(95%CI: 1.1–3.8 minutes) compared to the Mogen and 2.0 minutes longer (95%CI:0.7–3.4 
minutes) compared to the Plastibell procedures. The mean number of procedures to 
competency was 10.3 (SD:+/−3.3) for Gomco, 10.3 (SD:+/−3.7) for Plastibell and 8.9 (SD:
+/−2.9) for the Mogen clamp. All providers were competent in each circumcision method by 
fifteen procedures. In general, nurses took longer to train than the other providers but this 
was not statistically significant.
Adverse events
Treating participants with missing follow-up data as missing at random, the overall adverse 
event rate was 31/630 (4.9%, 95% CI: 3.4%–6.9%). When patients missing a follow-up visit 
were classified as having an adverse event, the overall adverse event rate was 41/640 (6.4%, 
95% CI: 4.6% − 8.6%). The 31 documented adverse events included 5 (16%) which were 
mild adverse events, 10 (32%) which were moderate events, and 16 (52%) which were 
severe events. All of the mild events were bleeding events requiring pressure to stop. The 
ten moderate complications included bleeding needing either Surgicel or a suture to 
attenuate. The sixteen severe complications included 11 cosmetic issues requiring revisions, 
one retained Plastibell that required removal in the theatre, three infections requiring 
intravenous antibiotics and hospitalization, and one transfusion for bleeding in a patient who 
was delayed on the way to the tertiary hospital. The overall adverse event rate did not differ 
by method (p=0.609). There were more cosmetic complications with the Mogen clamp 
compared to the other methods. (Table 4)
Discussion
In this prospective study, one of the largest to date of neonatal circumcision in Africa (18), 
and the only operational study of its kind, we show that neonatal circumcision can be 
provided by a variety of health care providers with relatively low complication rates (4.9%). 
We also found that most providers preferred the Mogen clamp over the Gomco and 
Plastibell techniques. We observed that providers were more likely to remove insufficient 
skin with the Mogen clamp, prompting surgical revision. However, this was not statistically 
significant given the small sample size of our study and the infrequent occurrence of these 
events.
Our complication rates were relatively low, but higher than rates of other studies from the 
United States. Between 1963 and 1972, Gee and colleagues retrospectively analyzed almost 
6,000 infants who had been circumcised in the United States; approximately half of the 
infants had been circumcised with the Gomco method and half with the Plastibell method. 
The overall complication rate was 0.2% with no significant difference between the two 
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different methods(12). Another study of NMC from Israel also report very low complication 
rates at 0.003% with almost all related to hemorrhage, cosmetic, and penile trauma which is 
consistent with our causes of morbidity. (14). A few studies in Africa have reported 
complication rates as high as 20% (19). Our complication rates may be slightly higher than 
those observed in other studies, given that we classified any post-procedure bleeding as an 
adverse event – even if it was mild. We also categorized any surgical revision for redundant 
foreskin as a severe adverse event, whereas other studies have typically excluded cosmetic 
events. In addition, since our study involved newly trained providers (as opposed to 
providers who had performed hundreds of procedures) we think it is safe to assume that our 
complication rates represent the upper limit of what could be expected in real practice. As 
providers perform more circumcisions and become more skilled, complication rates are 
likely to decline further. (9)
A recognized weakness of our study is that we did not perform individual infant 
randomization, but rather chose to assign the providers to different orders of the procedures. 
Individual randomization would have interfered with analysis of the provider training, as 
skill development is most easily achieved through repetition of the same technique a number 
of times in a short time frame. One result of our study design was imbalance between 
allocations groups. For example, more infants of Asian descent were included in the Mogen 
method group compared to the other methods, a result of patient clustering. We believe that 
this can be attributed to similar groups of mothers being brought to the clinic together on a 
given day by one woman from the community.
In our study, all types of providers preferred the Mogen clamp. This method has many 
benefits: one size can be used for all clients, the instrument consists of only one piece 
(versus the Gomco clamp which contains several pieces which much fit together); and it can 
be sterilized for re-use which may reduce on cost. Our safety outcomes were not 
significantly different between physicians and nurses although we had relatively few 
complications. Given the limited number of physicians (the physician patient ratio is 
1:14,000 and WHO recommendation is 1:5,000), this method will lend itself to easier scale 
up using mid level providers. In general, we found that it did take longer for nurses to 
achieve competency compared to the other types of trainees.
Conclusion
As Southern African countries turn their attention to scaling up early infant circumcision 
services for future prevention of male HIV acquisition, strategic decisions must be made 
regarding which method(s) to employ and which types of providers to train. We recommend 
that countries adopt and focus on a single NMC method, to ensure standardization in 
provider proficiency, to streamline training and procurement, and to minimize 
complications. Finally, given that the relatively high complication rates for NMC – 
particularly when compared to industrialized country settings – carefully monitoring of 
adverse events is urgently needed and systems to ensure ongoing clinical mentorship and 
training should be implemented.
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Diagram of infants enrolled into the neonatal circumcision study
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